Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 101–118 of 118 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05821686	Efficacy of Interleukin-2 in Triple Negative Breast Cancer	not yet recruiting	Phase 1 / Phase 2	10	Nova Scotia Health AuthorityOTHER	0	Feb 12, 2025	clinicaltrials
NCT06822985	QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma(QL1706)	not yet recruiting	Phase 1	21	Wan-Guang ZhangOTHER	1	Feb 12, 2025	clinicaltrials